You are here:
Pharma & Chemicals — Functional Products & Energy
Last Updated:February 28, 2026
About This Investor
JP-B-685
With roots in Japan, they are currently screening targets across Thailand, Singapore, Indonesia, Malaysia, Vietnam, Philippines, Australia (priority given to Thailand and Indonesia). EBIT of over 100 million yen (around 500 million yen is better) Minority investment, majority ownership, and 100% ownership are possible. Key target profile: Pharmaceuticals, fine chemicals, functional chemicals, health foods Trading…
Pharmaceuticals & Chemicals
Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam
Diversification
Not disclosed
EBIT ≥ USD 0.65M (USD 3.3M+ ideal) | Minority/Majority/100% possible
Request Full Investor Profile
Similar Investors
JP-B-323
Headquartered in Japan, they are seeking targets that match the
Logistics & Transportation
Worldwide
Strategic Expansion
$13.1M - $65.4M
Majority / 100% | Revenue ≥ USD 19.6M
JP-B-620
Japan – based, this investor is building pipeline coverage and
Civil Engineering
Worldwide
Overseas Expansion
$65.4M
Majority / 100% | Revenue ≥ USD 13.1M
JP-B-553
From Japan, they are currently screening targets across Thailand is
Industrial Manufacturing (Fasteners)
ASEAN, India, Thailand
Strategic Expansion
$6.54M - $19.6M
100% (rule) | Majority required | Revenue USD 9.8M–13.1M | Op margin ≥10% preferred